News & Analysis
Genentech and Regeneron win Thomson Reuters Allicense Awards for Top BioPharma Deals of the Year
Genentech and Regeneron win Thomson Reuters Allicense Awards for Top BioPharma Deals of the Year

The Intellectual Property and Science business of Thomson Reuters recently honoured Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year.

More
Share
News & Analysis
Merck Millipore Acquire Exclusive Rights to Singulex Single Molecule Counting Technology
Merck Millipore Acquire Exclusive Rights to Singulex Single Molecule Counting Technology

Merck Millipore and Singulex, the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, have announced that they have entered into a definitive

More
Share
News & Analysis
Advanced Cell Diagnostics raises $22 million USD in latest round of financing
Advanced Cell Diagnostics raises $22 million USD in latest round of financing

Advanced Cell Diagnostics (ACD) have raised a further $22 million in Series C equity financing, with proceeds to be used to accelerate their entry into the research and clinical diagnostics

More
Share
News & Analysis
Kite Pharma & bluebird bio Announce Strategic Collaboration to Treat HPV-Associated Cancers
Kite Pharma & bluebird bio Announce Strategic Collaboration to Treat HPV-Associated Cancers

With the Cancer Immunotherapy market forecast to increase to $9 billion by 2022, it’s no surprise that the burgeoning sector has attracted the attention of biotech and pharma investors across

More
Share
News & Analysis
Merck Acquisition of Sigma-Aldrich receives conditional clearance from European Commission
Merck Acquisition of Sigma-Aldrich receives conditional clearance from European Commission

Sigma-Aldrich’s acquisition by Merck has been conditionally cleared by the European Commission, and has received full clearance from the Chinese Ministry of Commerce. Merck and Sigma have already cleared from

More
Share
News & Analysis
Evolution Global Talent Attraction featured on GEN JobWatch
Evolution Global Talent Attraction featured on GEN JobWatch

Evolution founder and Managing Director Dr. Jason Beckwith was recently featured on monthly Genetic Engineering & Biotechnology News column JobWatch. Dr. Beckwith offered GEN an insight into the hiring practices

More
Share
News & Analysis
Sigma-Aldrich Announce Q1 2015 Sales Figures
Sigma-Aldrich Announce Q1 2015 Sales Figures

Sigma-Aldrich Corporation have posted strong Q1 2015 results ahead of their planned merger with Merck later this year. Sigma reported quarterly sales of $676 million, with an organic growth rate

More
Share
News & Analysis
Merck appoints Udit Batra to head combined life science business ahead of Sigma-Aldrich acquisition
Merck appoints Udit Batra to head combined life science business ahead of Sigma-Aldrich acquisition

Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed later this year. Udit

More
Share
News & Analysis
Scottish CRO BioOutsource Acquired by Sartorius Stedim Biotech
Scottish CRO BioOutsource Acquired by Sartorius Stedim Biotech

Scottish Contract Research Organisation BioOutsource have been acquired by global biopharmaceutical supplier Sartorius Stedim Biotech (SSB) for an undisclosed amount. The takeover strengthens SSB’s service portfolio throughout the drug development

More
Share
News & Analysis
Sigma-Aldrich Launch New APAC Headquarters and Cell Culture Technical Center
Sigma-Aldrich Launch New APAC Headquarters and Cell Culture Technical Center

Global Life Science and High Technology company Sigma-Aldrich announced the opening of their new Asia Pacific headquarters and state-of-the-art Cell Culture Technical Center at the Biopolis Research Park in Singapore.

More
Share
News & Analysis
Bio-Rad Reports Strong Fourth-Quarter and Full-Year 2014 Financial Results
Bio-Rad Reports Strong Fourth-Quarter and Full-Year 2014 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced financial results today for the fourth quarter and fiscal year ended

More
Share
News & Analysis
Plant Impact and Bayer CropScience enter multi-year partnership
Plant Impact and Bayer CropScience enter multi-year partnership

Plant Impact plc today announced that it has signed an agreement with Bayer CropScience to develop yield enhancing technologies for soy cultivation. The agreement encompasses a multi-year partnership for Plant

More
Share